Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

CD Antigens 1996

T. Kishimoto, S. Goyert, H. Kikutani, D. Mason, M. Miyasaka, L. Moretta, T. Ohno, K. Okumura, S. Shaw, T.A. Springer, K. Sugamura, H. Sugawara, A.E.G.Kr. von dem Borne, H. Zola

Blood (1997) 89 (10): 3502.

https://doi.org/10.1182/blood.V89.10.3502

Published: 1997

Journal Articles

Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia [letter]

H Tamaki, H Ogawa, K Inoue, T Soma, T Yamagami, S Miyake, Y Oka, Y Oji, T Tatekawa, A Tsuboi, S Tagawa, T Kitani, K Aozasa, T Kishimoto, H Sugiyama, H Miwa, K Kita

Blood (1996) 88 (11): 4396–4398.

https://doi.org/10.1182/blood.V88.11.4396b.4396b

Published: 1996

Journal Articles

Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

K Inoue, H Ogawa, T Yamagami, T Soma, Y Tani, T Tatekawa, Y Oji, H Tamaki, T Kyo, H Dohy, A Hiraoka, T Masaoka, T Kishimoto, H Sugiyama

Blood (1996) 88 (6): 2267–2278.

https://doi.org/10.1182/blood.V88.6.2267.bloodjournal8862267

Published: 1996

Journal Articles

Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan

S Hashimoto, S Tsukada, M Matsushita, T Miyawaki, Y Niida, A Yachie, S Kobayashi, T Iwata, H Hayakawa, H Matsuoka, I Tsuge, T Yamadori, T Kunikata, S Arai, K Yoshizaki, N Taniguchi, T Kishimoto

Blood (1996) 88 (2): 561–573.

https://doi.org/10.1182/blood.V88.2.561.bloodjournal882561

Published: 1996

Journal Articles

Interleukin-6 family of cytokines and gp130

T Kishimoto, S Akira, M Narazaki, T Taga

Blood (1995) 86 (4): 1243–1254.

https://doi.org/10.1182/blood.V86.4.1243.bloodjournal8641243

Published: 1995

Journal Articles

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis

Y Shima, N Nishimoto, A Ogata, Y Fujii, K Yoshizaki, T Kishimoto

Blood (1995) 85 (3): 757–764.

https://doi.org/10.1182/blood.V85.3.757.bloodjournal853757

Published: 1995

Journal Articles

Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction [see comments]

A Ogata, N Nishimoto, Y Shima, K Yoshizaki, T Kishimoto

Blood (1994) 84 (9): 3040–3046.

https://doi.org/10.1182/blood.V84.9.3040.3040

Published: 1994

Journal Articles

CD antigens 1993

SF Schlossman, L Boumsell, W Gilks, JM Harlan, T Kishimoto, C Morimoto, J Ritz, S Shaw, RL Silverstein, TA Springer

Blood (1994) 83 (4): 879–880.

https://doi.org/10.1182/blood.V83.4.879.879

Published: 1994

Journal Articles

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

M Narazaki, K Yasukawa, T Saito, Y Ohsugi, H Fukui, Y Koishihara, GD Yancopoulos, T Taga, T Kishimoto

Blood (1993) 82 (4): 1120–1126.

https://doi.org/10.1182/blood.V82.4.1120.1120

Published: 1993

Journal Articles

Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients

D Emilie, J Coumbaras, M Raphael, O Devergne, HJ Delecluse, C Gisselbrecht, JF Michiels, J Van Damme, T Taga, T Kishimoto

Blood (1992) 80 (2): 498–504.

https://doi.org/10.1182/blood.V80.2.498.498

Published: 1992

Journal Articles

Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6

S Natsuka, S Akira, Y Nishio, S Hashimoto, T Sugita, H Isshiki, T Kishimoto

Blood (1992) 79 (2): 460–466.

https://doi.org/10.1182/blood.V79.2.460.460

Published: 1992

Journal Articles

Interleukin-6 is a potent thrombopoietic factor in vivo in mice

T Ishibashi, H Kimura, Y Shikama, T Uchida, S Kariyone, T Hirano, T Kishimoto, F Takatsuki, Y Akiyama

Blood (1989) 74 (4): 1241–1244.

https://doi.org/10.1182/blood.V74.4.1241.1241

Published: 1989

Journal Articles

The biology of interleukin-6

T Kishimoto

Blood (1989) 74 (1): 1–10.

https://doi.org/10.1182/blood.V74.1.1.1

Published: 1989

Journal Articles

Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues

FM Uckun, A Muraguchi, JA Ledbetter, T Kishimoto, RT O'Brien, JS Roloff, K Gajl- Peczalska, A Provisor, B Koller

Blood (1989) 73 (4): 1000–1015.

https://doi.org/10.1182/blood.V73.4.1000.1000

Published: 1989

Journal Articles

Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3)

S Shimizu, T Hirano, R Yoshioka, S Sugai, T Matsuda, T Taga, T Kishimoto, S Konda

Blood (1988) 72 (5): 1826–1828.

https://doi.org/10.1182/blood.V72.5.1826.1826

Published: 1988

Journal Articles

Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages

J Bauer, U Ganter, T Geiger, U Jacobshagen, T Hirano, T Matsuda, T Kishimoto, T Andus, G Acs, W Gerok

Blood (1988) 72 (4): 1134–1140.

https://doi.org/10.1182/blood.V72.4.1134.1134

Published: 1988

Journal Articles

Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma

H Asaoku, M Kawano, K Iwato, O Tanabe, H Tanaka, T Hirano, T Kishimoto, A Kuramoto

Blood (1988) 72 (2): 429–432.

https://doi.org/10.1182/blood.V72.2.429.429

Published: 1988

NARROW

CD Antigens 1996

Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia [letter]

Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan

Interleukin-6 family of cytokines and gp130

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis

Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction [see comments]

CD antigens 1993

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients

Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6

Interleukin-6 is a potent thrombopoietic factor in vivo in mice

The biology of interleukin-6

Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues

Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3)

Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages

Decrease in BSF-2/IL-6 response in advanced cases of multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only